Overview

A Safety Study of PTI-125 in Healthy Volunteers

Status:
Completed

Trial end date:
2018-03-27

Target enrollment:

Participant gender:

Summary

A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Pharmacokinetic and Safety Study of PTl-125 in Healthy Volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Pain Therapeutics

Collaborators:

National Institute on Aging (NIA)
National Institutes of Health (NIH)